Cornelis M. van Tilburg

The landscape of genomic alterations across childhood cancers

Susanne Gröbner, Barbara C. Worst, Joachim Weischenfeldt et al. · Nature · 2018 · 1.6K citations · Full text

Medicine, Genetics, Oncology +17

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong, Steven G. DuBois, Shivaani Kummar et al. · The Lancet Oncology · 2020 · 994 citations · Full text

Medicine, Oncology, Immunotherapy +14

Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian et al. · European Journal of Cancer · 2016 · 336 citations · Full text

Medicine, Oncology, Pediatrics +11

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler et al. · Cancer Discovery · 2021 · 260 citations · Full text

Medicine, Oncology, Pediatrics +13

Refined characterization and reference values of the pediatric T- and B-cell compartments

Rogier van Gent, Cornelis M. van Tilburg, Elisabeth E. Nibbelke et al. · Clinical Immunology · 2009 · 178 citations

Life Sciences, Immunology, Pediatrics +15